Renal Denervation Market– Overview
The surge in blood pressure cases due to increased exposure to causative factors is spurring the need for renal denervation. Market reports associated with the healthcare industry has been offered by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is anticipated to develop at a CAGR of 40.4% while raking in revenues valued at USD 2,850 million in the forecast period.
The advances in drug therapy and surgical procedures is boosting the renal denervation market considerably. The escalation in the number of hypertension cases globally is creating substantial demand for the market. The improvements in the healthcare sector are also adding to the overall growth of the market for renal denervation. Furthermore, increased level of investment in the research and development of treatment methods is expected to bolster the market expansion in the upcoming forecast period.
Get Sample Copy at https://www.marketresearchfuture.com/sample_request/6712
Nov 2018 Medtronic has recently announced that the FDA has permitted the company to initiate an investigational device exemption trial of a renal denervation system for the treatment of hypertension in patients who are already taking antihypertensive medications. The system called Symplicity Spyral will be tried in the SPYRAL HTN-ON MED trial, a potential, randomized, sham-controlled study of up to 340 patients for three years.
The segmentation of the renal denervation market is segmented on the basis of technology, product, region and end use.
Based on product, the renal denervation market is segmented into Vessix (V2), Symplicity, Iberis, EnligHTN, Paradise, and others.
Based on technology, the renal denervation market is segmented into ultrasound, radiofrequency, micro-infusion, and others.
On the basis of end user, the market for renal denervation is segmented into ambulatory surgical centers, hospitals, clinics, and others.
The regions included in the renal denervation market is segmented into Europe, North America, Asia Pacific, and Rest of the world.
Detailed Regional Analysis
The regional analysis of the renal denervation market includes regions such as Asia Pacific, Europe, North America, Middle East, and Africa. The European region is likely to command the renal denervation market globally over the forecast period owing to the strong research organization in the region and the growing development of increasingly more progressive renal denervation devices. The growing incidence of drug-resistant hypertension in the European region is further expected to drive research in the renal denervation market, ensuring the European region’s lead in the renal denervation market in the forecast period. The Asia Pacific region is also projected to be a key regional market for renal denervation in the forecast period owing to the rising incidence of hypertension and the stable development in the healthcare infrastructure. This is expected to confirm the extensive accessibility of renal denervation devices as well as growing research into product development to create more advanced renal denervation devices in the forecast period.
Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/renal-denervation-market-6712
The market also shows potential for demonstrating a greater comparative or differential value. The presence of a productive entity is expected to generate more sales or superior margins compared to its market rivals. The market trends hint at favorable development of the products that can bring in novelty to the product range and address the customer need better. The advent of new technology has boosted the growth potential of the market. Substantial cutbacks in administrative finances are bringing further development to the market. The development of a strong value chain is moreover motivating the expansion of the market. The market competitors find themselves in a favorable position with the ability to manage the pace of change. The regions included in the renal denervation market are Medtronic, Boston Scientific, ReCor Medical, St. Jude Medical, Cardiosonic, Kona Medical, Cordis, Sound Intervention, and Terumo.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Renal Denervation Market, By Product
Chapter 7. Global Renal Denervation Market, By Technology
Chapter 8. Global Renal Denervation Market, By End-User Type
Chapter 9. Global Renal Denervation Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
- LIST OF TABLES
- LIST OF FIGURES
Avail discount at https://www.marketresearchfuture.com/check-discount/6712
Renal Denervation Market Research Report: by Product (Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis, Others), by Technology (Radiofrequency, Ultrasound, Micro-infusion, and Others), by End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Region – Forecast To 2023
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312